352
R.P. Dhankar et al. / Spectrochimica Acta Part A 93 (2012) 348–353
Table 4
role in various metabolic pathways of these microorganisms. Other
Powder XRD data of metal complexes.
factors such as solubility, conductivity and dipole moment which
affected by the presence of metal ions, may also be possible rea-
sons for increasing the biological activity of the metal complexes
as compared to the corresponding ligand.
Data
CPMC
MPMC
Chemical formula
Molecular weight (g/mol)
Crystal system
C42H36CuN4O10
819.32
Triclinic
P−1
C43H38MnN4O10
825.72
Triclinic
P−1
Space group
4. Conclusion
Unit cell dimensions
a
b
c
˛
ˇ
ꢆ
4.9168
4.9865
5.4089
78
90
104
4.9160
4.9153
5.4084
82
85
115
MPMC, CPMC, NPMC and ZPMC complexes were synthesized
and characterized. Analytical data, electronic spectra, magnetic
susceptibility, IR and 1H NMR have been revealed octahedral geom-
etry of MPMC and square planar geometry of CPMC, NPMC and
ZPMC, respectively. The low conductance values showed non-
electrolytic behaviour of the complexes. Single crystals of the
compounds could not be isolated; however, powder XRD data,
spectroscopic and magnetic data enabled us to elucidate possible
structures. The complexes were evaluated in vitro for the antibacte-
rial and the antifungal activities. All metal complexes had effective
and selective antibacterial activity against bacterial strains. The
results speculate regions for higher activity of complexes: (1)
the metal complexes could be inactivated to several structural
enzymes, catalysing biosynthetic reactions inessential metabolic
pathways of the microorganisms; and (2) they act as a whole, are
able to cross the cell membranes and interfere with the vital cell
mechanisms including DNA replication, transcription, and protein
synthesis.
Volume
132.61
6.1
299 K
130.68
6.3
299 K
(Calc.) density (g/cm−3
Temperature
)
patterns of the complexes are in agreement with the theoretical
data. All complexes decompose in three major phases.
The first phase corresponds to the loss of 2 moles of acetate
ions between 100 and 300 ◦C with mass losses of (obs. = 14.26%,
calc. = 14.31%). The second phase is from 305 to 410 ◦C and is
attributed to the loss of the organic moiety of styryl and phenyl
ring with mass losses of C8H7 (obs. = 24.91%, calc. = 25.1%). The final
phase shows the loss of the organic moiety of pyrimidine and
phenyl ring of 408 at 450–800 ◦C with mass losses of (obs. = 49.53%,
calc. = 49.33%) leaving metal oxides as residues.
Acknowledgements
RPD gratefully acknowledges UGC, New Delhi for financial assis-
tance under faculty improvement program of XI plan. The authors
wish to express their gratitude to the Department of Pharmacy,
Nagpur for IR spectroscopic analysis; the Sophisticated Analytical
Instrumentation Facility (SAIF), Chandigarh for 1H NMR spectro-
scopic analysis and mass analysis; and the University of Pune, Pune
for 13C NMR spectroscopic data. We also wish to acknowledge
Metallurgical and Materials Engg. Department, VNIT, Nagpur for
TGA–DTA analysis and Powder XRD; and Department of Chemistry,
R.T.M. University, Nagpur for magnetic moment. We do acknowl-
edge Department of Physics, Institute of Science, Nagpur for UV
spectral data.
3.8. In vitro biological evaluation
The ligand and its metal complexes were evaluated for antimi-
crobial activity against one strain Gram positive bacteria (S. aureus)
(a), Gram negative bacteria(E. coli) (b), fungus (Candida albicans) (c)
and fungus F. solani (d) and the results are summarized in Table 5.
The ligand was found to be biologically active and their metal com-
plexes enhanced antimicrobial activity against one or more strain.
Remarkably, the complexes showed appreciable inhibition against
S. aureus (a), C. albicans (c) and F. solani (d) ranging from 43 to
86%. It is known that chelation tends to make the ligand a more
powerful and potent bactericidal agent. A possible explanation for
the observed increased activity upon chelation is that the positive
charge of the metal in chelated complex is partially shared with
the ligand’s donor atoms so that there is an electron delocalization
over the whole chelate ring. This, in turn, will increase the lipophilic
character of the metal chelate and favours its permeation through
the lipoid layers of the bacterial membranes. Typically, chelated
complexes deactivate various cellular enzymes, which play a vital
References
[1] A.D. Tiwari, A.K. Mishra, S.B. Mishra, B.B. Mamba, B. Maji, S. Bhattacharya, Spec-
trochim. Acta A: Mol. Biomol. Spectrosc. 79 (2011) 1050.
[2] S.M. Mamba, A.K. Mishra, B.B. Mamba, P.B. Njobeh, M.F. Dutton, E.
Fosso-Kankeu, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 77 (2010)
579.
[3] A.K. Mishra, N.K. Kaushik, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 69
(2008) 842.
[4] A.K. Mishra, N. Manav, N.K. Kaushik, Spectrochim. Acta A: Mol. Biomol. Spec-
trosc. 61 (2005) 3097.
[5] A.K. Mishra, S.B. Mishra, N. Manav, R. Kumar, Sharad, R. Chandra, D. Saluja, N.K.
Kaushik, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 66 (2007) 1042.
[6] N. Manav, A.K. Mishra, N.K. Kaushik, Spectrochim. Acta A: Mol. Biomol. Spec-
trosc. 65 (2006) 32.
Table 5
In vitro antimicrobial activity of ligand and its metal complexes.
Compound
a
b
c
d
[7] F. Hueso, N.A. Illan, M.N. Moreno, J.M. Martinez, M.J. Ramirez, J. Inorg. Biochem.
94 (2003) 326.
[8] S.P. Fricker, Dalton Trans. (2007) 49030.
[9] T.W. Hambley, Dalton Trans. (2007) 4929.
[10] P.G. Baraldi, M.G. Pavani, N. Nunes, P. Brigidi, B. Vitali, R. Gambari, R. Romagnoli,
Arch. Pharm. 10 (2002) 449.
Ligand (ADP)
NPMC
CPMC
+++
++
+++
++++
++++
++
+++
+
++
++
++
++
++
+
++
+
+++
+++
+++
+++
+++
+++
ZPMC
MPMC
Cephalosporina
Streptomycinb
+++
+++
++++
++
[11] S.M. Sondhi, M. Johar, S. Rajvanshi, S.G. Dastidar, R. Shukla, R. Raghubir, J.W.
Lown, Aust. J. Chem. 54 (2001) 69.
[12] M.N. Nasr, M.M. Gineinah, Arch. Pharm. 335 (2002) 289.
[13] N. Kumar, G. Singh, A.K. Yadav, Heteroat. Chem. 12 (2001) 52.
[14] G. Mangalagiu, M. Ungureanu, G. Grosu, L. Mangalagiu, M. Petrovanu, Ann.
Pharm. Fr. 59 (2001) 139.
a, S. aureus; b, E. coli; c, Candida albicans; d, F. solani.
a
Standard antifungal agent.
Antibacterial agents.
b
Inhibition zone diameter in nm (% inhibition): (+) 8–10 (36–45%); (++) 10–16
(45–73%); (+++) 16–19 (73–86); (++++). Percent inhibition values are relative to
inhibition zone (22 mm) (100%).
˙
[15] M. Sönmeza, M. C¸ elebib, A. Leventb, I. Berberc, Z. S¸ entürkb, J. Coord. Chem. 63
(2010) 1986.
[16] Azaroff, Buerger, The Powder Method, McGraw Hill, London, 1958.